Skip to main content
OpenTrials
Completed

NCT Number: NCT00463138

Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Exclusion criteria

  • Clients under the age of 12

Treatment and study plan

Crisis Intervention

Behavioral

Primary outcomes

  1. depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning.

    Time frame: April 2007- March 2008

Secondary outcomes

  1. level of family, friend, and other support, Self-Efficacy Scale

    Time frame: Aprol 2007- March2008

Other outcomes

  1. Traumatic Events Screening Inventory (TESI)

    Time frame: April 2008- March 2008

Sponsors and collaborators

Lead sponsor

Herzog Hospital

Other

Registry information

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Apr 20, 2007
Registry last updated
Sep 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.